Lynchburg Hematology-Oncology Clinic
1701 Thomson Dr #200
Lynchburg, Virginia 24501
(434) 200-5925 http://www.lynchburgoncology.com

Use our guide to learn which trials are right for you!

Lynchburg Hematology Oncology is a medical oncology and hematology practice located on the second floor of the Alan B. Pearson Regional Cancer Center in Lynchburg, Virginia. Our physicians and staff are committed to providing compassionate and comprehensive care to patients with cancer and blood disorders. The practice is QOPI® certified by the American Society of Clinical Oncology and offers clinical trials in partnership with various local, regional, and national healthcare organizations. Appointments are by referral only.

We've found
7 trials
at this facility
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 4/7/2016
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials